Stroke

Published on 27/02/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1267 times

Chapter 37

Stroke

Stroke is an important cause of mortality and long-term neurologic morbidity in children. In the pediatric age group, it is defined as a cerebrovascular event occurring between 14 weeks of gestation and 18 years of life. It ranks among the top 10 causes of death in children,1 with the highest incidence observed in the perinatal period. It occurs in approximately 25 per 100,000 live births in the neonatal population and in 2 to 3 per 100,000 in children between 30 days and 18 years. Recurrence is estimated to be around 3% to 5% in neonates and ranges from 20% to 40% in older children. Among those who survive, more than 50% progress to the development of permanent neurologic or cognitive sequelae.2 The required treatment and rehabilitation programs usually result in a large economic burden to the family and society (Box 37-1).

The reported incidence of pediatric stroke has been on the rise, perhaps because of increased awareness among medical professionals, but also because of improved diagnostic imaging techniques. In the past, infectious processes such as meningitis often were found, but today congenital heart disease, sickle cell anemia, extracranial carotid dissection, and thrombophilia constitute most cases. Even though it often is possible to identify more than one risk factor, in approximately 50% of cases, a definite cause remains undetermined. Clinical management of children who have had a stroke remains controversial, despite the fact that treatment algorithms have been established for adults.

Fetal Stroke

Fetal stroke occurs between 14 weeks of gestation until the onset of labor. Because of the lack of maternal or otherwise detectable fetal symptoms, the true incidence of fetal stroke is unknown; usually it is only diagnosed incidentally by antenatal ultrasound performed late in the second trimester or in the third trimester. Sometimes a fetal stroke is detected only during the neonatal period or later in life when developmental delays become perceptible.

Maternal, placental, and fetal risk factors have been reported, but in more than 50% of cases, no obvious cause is found. The common maternal conditions associated with fetal stroke are alloimmune thrombocytopenia, diabetes, anticoagulant or antiepileptic therapy, and trauma. Placental factors include placental hemorrhage, abruption, and thromboemboli.3 It is unclear whether coagulopathy is a risk factor, but a case of fetal protein C deficiency has been reported.

Intraparenchymal hemorrhage, cerebral cavitary lesions, and ventriculomegaly are common findings on antenatal ultrasound. These findings are not specific for the type of stroke; however, the location of the injury and the distribution (arterial or venous) may suggest an underlying mechanism. Acute injury and small ischemic lesions can be difficult to detect with ultrasound.

Once an abnormality is found on a prenatal ultrasound examination, fetal magnetic resonance imaging (MRI) usually is performed; it is the imaging modality of choice for assessing fetal brain injury (Fig. 37-1). Hemorrhagic lesions have been reported in more than 90% of cases, compared with porencephalic cysts, which are reported in 10% of cases. Arterial ischemic stroke (AIS) typically involves the major arterial territories, most commonly the middle cerebral artery (MCA). Arterial ischemic insults occurring in the second trimester can cause cortical disorganization, resulting in polymicrogyria. If fetal hemorrhagic strokes are similar in origin to the vast majority of preterm and term hemorrhages, it is likely that many fetal hemorrhagic strokes are venous strokes. When tissue destruction occurs as a result of a fetal stroke, the type of tissue response identified on postnatal imaging can help determine the time of the intrapartum event. Porencephalic cysts lack a surrounding astroglial response and develop with injuries between 22 and 27 weeks of gestation. Thereafter, cystic encephalomalacia with gliosis is seen on pathology and MRI. Unlike in neonates and adults, diffusion-weighted imaging (DWI) may not be reliable in predicting the approximate date of an event.4

Finally, although a fetal stroke is often subclinical, strokes identified by prenatal screening are typically large and result in death or an adverse neurodevelopmental outcome in more than three quarters of cases.

Perinatal or Neonatal Stroke

Perinatal or neonatal stroke is an event that occurs between the late third trimester and the first month of life. The pathophysiology is complex and typically multifactorial. Recently, prothrombotic abnormalities of the coagulation pathway have been of particular interest because of the evolving role and potential use of antithrombotic agents for both treatment and prevention.5

It is important to differentiate ischemic stroke from hypoxic-ischemic injury, even though both can coexist, because management and prognosis can be different.

Arterial Ischemic Stroke

Perinatal AIS leads to focal ischemic necrosis in an arterial distribution, most commonly in the MCA territory. The cause is undetermined in more than half of all cases. In the remainder of cases, the source of the thromboemboli may be an intracranial or extracranial vessel, the heart, or the placenta. An increased incidence of dehydration and sepsis also is found, along with cardiac and coagulation disorders.2 AIS may be clinically subtle, and newborns often present with seizures without encephalopathy 2 to 3 days after birth. At the time of clinical presentation, ultrasound of the head can be have false-negative results. Computed tomography (CT) can detect hemorrhage and areas of advanced infarction but also may have false-negative results. Furthermore, ionizing radiation exposure is discouraged in neonates. Acute AIS is easily identified on MRI as regions of bright signal on DWI and decreased signal on apparent diffusion coefficient (ADC) maps within a vascular territory. The reduction in ADC values results from the presence of acute ischemic necrosis and the associated physiologic changes, such as cellular swelling, increased tortuosity of the extracellular space, decreased intracellular cytosolic streaming, and increased intracellular viscosity. The reduction in ADC can persist for up to 2 weeks, being more conspicuous during the first 4 days.6

On T2-weighted images, subtle loss of gray-white matter differentiation often is identified, although it may be negative within the first hours after clinical presentation. MR angiography (MRA) may be helpful in excluding complete occlusion of a major intracranial artery, but turbulent or fast flow often can result in signal dropout, which generates a concern for partially occlusive thrombus in this clinical context. Cerebral perfusion can be obtained using arterial spin labeling. This technique uses arterial blood water magnetically labeled by a radiofrequency pulse to obtain cerebral blood flow measurements; it does not require intravenous injection of contrast media (see Chapter 28). This technique can be particularly useful in determining the presence of reperfusion in areas of abnormal ADC (Fig. 37-2).7

Ultrasound of the head combined with color and pulsed Doppler imaging remains a useful technique to evaluate the circle of Willis, in particular the regions of signal loss on MRA. If an intraluminal clot is identified or confirmed, bedside Doppler imaging can be used to monitor for recanalization and decreases in resistive indices that may occur as a result of secondary hyperperfusion.

In two thirds of patients, neurologic deficits with hemiplegia develop if the posterior limb of the internal capsule, motor strip, or basal ganglia is involved on the initial studies.

On long-term follow-up, regions of AIS can evolve into regions of volume loss, glial scarring, or cystic encephalomalacia, depending on the severity of the injury.

AIS also can develop as a result of bacterial meningitis as inflammatory cells infiltrate the vessel wall, leading to foci of necrosis that incite thrombosis of the arteries or veins coursing through the infected space (Fig. 37-3).

Venous Stroke

Venous strokes are associated with vasogenic edema, hemorrhage, and ischemic necrosis in a venous distribution. A venous stroke can occur as a result of transient mechanical or thrombotic occlusion of a vein or venous sinus. Newborns present with nonspecific symptoms related to increased intracranial pressure, lethargy, or seizures. A significant proportion of neonatal sinovenous thrombosis (SVT) is classified as idiopathic, but risk factors include dehydration, sepsis, asphyxia, maternal diabetes, and thrombophilia.8 Isolated SVT has a good prognosis, except in rare cases when the deep venous system becomes involved.

CT may show a hyperdense clot in the involved vein or venous sinus and can identify intraventricular hemorrhage seen with involvement of the deep venous system. MRI is the preferred modality for confirming the diagnosis and determining the presence and extent of the associated brain injury. T2* gradient-echo or susceptibility-weighted images are particularly useful in demonstrating the thrombus as a region of “blooming” in the venous system and detecting intraparenchymal hemorrhage (Fig. 37-4 and Boxes 37-2 and 37-3). On follow-up examinations, brain parenchyma affected by a venous stroke can show atrophy or can almost completely resolve, depending on the severity and duration of the injury.

Ultrasound can be used to visualize the echogenic clot at the bedside and to monitor its evolution. It also can be used to screen for additional complications, such as hydrocephalus as a result of intraventricular hemorrhage.

Childhood Stroke

The incidence of childhood stroke based on imaging findings is estimated to be 2.4 cases per 100,000 patient population.9 Cerebrovascular insults in children can be categorized as AIS or SVT.

Arterial Ischemic Stroke

In more than half of childhood cases of AIS, the precise etiology is never determined. In the remaining cases, a variety of pathologies are found, including thromboembolism (from intracranial or extracranial vessels, cardiac disorders such as congenital or acquired heart disease, intracardiac shunts, and procedures), arteriopathy (arterial dissection, moyamoya disease, vasculitis, sickle cell disease [SCD] arteriopathy, postvaricella angiopathy, and idiopathic focal cerebral arteriopathy), and hypercoagulable states (protein C or S deficiency, antithrombin III, and factor V Leiden mutation).10,11

SCD, a common risk factor for stroke in children, increases the risk of having a stroke approximately 200 to 400 times. The rigid, sickle-shaped red blood cells lead to vascular occlusion. Additionally, adherence to the vessel wall damages the intima and media, resulting in fibrosed and stenotic vessels. Proximal MCA or distal internal carotid artery branches are the most commonly involved vessels. In approximately 5% to 8% of patients with SCD, symptomatic cerebrovascular disease develops, and in about 20% of cases, a clinically silent stroke also may develop.

On imaging, acute infarction is usually superimposed on a diseased brain with atrophy and chronic changes. MRA commonly shows irregular stenotic arteries involving the anterior circulation with leptomeningeal collaterals, often longstanding. CT angiography (CTA) use is limited because iodinated contrast predisposes to sickling crises. Low osmolar agents should be used when iodinated contrast is deemed necessary, along with transfusion and hydration to reduce the risk of complications. Biannual screening with transcranial Doppler imaging is routinely performed, and abnormally elevated time-averaged mean velocities (>200 cm/sec) from stenotic arteries necessitates blood transfusion to prevent stroke.12 Brain MRI is usually performed to evaluate children with sickle cell anemia presenting with seizures or motor or sensory deficit.

Moyamoya disease accounts for approximately 6% of AIS incidence in Western countries. Moyamoya disease is a progressive vasculopathy causing stenosis of intracranial arteries with a predilection for terminal portions of the internal carotid arteries (Fig. 37-5). It can be associated with neurofibromatosis type 1, radiation vasculitis, Down syndrome, and SCD; if the cause remains undetermined, it is referred to as moyamoya disease. Collateral formation from the lenticulostriate vessels and thalamoperforators lead to a classic “puff-of-smoke” appearance on angiography. MRI can demonstrate loss of the normal flow void in the distal carotid branches on T2-weighted images, as well as development of abnormally large and irregular collateral vessels. Fluid attenuated inversion recovery images often show increased signal in distal vessels with decreased flow. Carotid stenosis also can be observed on MRA, but its severity can be overestimated because of slow and turbulent flow.13 Postcontrast MRA and, in particular, CTA can improve accuracy. DWI demonstrates acute areas of ischemic necrosis, whereas perfusion imaging and arterial spin labeling can demonstrate peripheral areas of delayed cerebral flow.

Arterial dissection may occur spontaneously or after trauma. Arterial dissection leads to formation of an intramural thrombus, which can propagate and embolize distally, or it can lead to vascular occlusion. The common locations are at the junction between relatively fixed and mobile segments of arteries and among the intracranial arteries; the supraclinoid internal carotid artery often is affected. T1-weighted fat-saturated sequences performed from the aortic arch to the cavernous sinus can demonstrate concentric hyperintense signal because of methemoglobin in the vessel wall in the subacute phase. If the dissection is recent, close inspection of the images is necessary to rule out isointense concentric wall thickening. If MRA is degraded by flow artifacts, CTA can be performed (Fig. 37-6). The angiographic findings are abrupt segmental narrowing with an intimal flap, a beaded appearance, or pseudoaneurysm formation.14

Mitochondrial disorders usually involve multiple systems, but the strokelike events that appear as focal neurologic deficits of abrupt onset can mimic and be clinically indistinguishable from AIS. Mitochondrial injuries do not follow the vascular boundaries, and on MRI, the ADC values are typically normal to elevated, as opposed to the classically low values seen with AIS6 (see Chapter 33).

The presence of transient neurologic symptoms in patients with migraine also can simulate stroke. Migraine with aura has been associated with increased risk for stroke in the adult population, and the literature includes some case reports of migrainous infarct in adolescents. The association between these two entities is thought to be related to a dysfunction of cerebral arteries during migraine bouts (Fig. 37-7).15

Venous Stroke

In children, SVT is the primary cause of venous stroke. Dehydration, complicated otitis media, and sinusitis are the major risk factors in older children. Less commonly, a prothrombotic disorder, trauma, or medication is the identified cause. If the superficial cortical veins are involved, SVT leads to regional cerebral edema, which has a good prognosis. SVT is demonstrated as hyperdensity on CT and variable signal intensity on conventional MRI sequences. MRI with susceptibility-weighted images, DWI, MR venography, and postcontrast volumetric T1 imaging are the sequences of choice. DWI is helpful for determining whether vasogenic edema or ischemic necrosis is present. Postcontrast volumetric T1 images provide direct visualization of filling defects in the venous system and allow secondary evaluation of regions of signal dropout on MR venography.16 Identification of the clot on susceptibility sequences is the best confirmation of SVT. If MRI is equivocal, CT venography can give a better delineation of the venous system, at the expense of radiation exposure (Fig. 37-8).

Summary

Stroke is a well-established entity in infants and children, where it is an important cause of morbidity and mortality. It can be a challenging diagnosis, despite imaging advances, because the diagnosis often is unsuspected and imaging is typically is ordered only in the subacute to chronic phase. In addition, the common presence of complex etiologies in children who have had a stroke is in marked contrast to the situation in adults, in whom stroke is almost always a result of atherosclerotic vascular disease. Management remains controversial in many situations because of the lack of understanding of etiology and the future risk of recurrent stroke. Increased awareness of the different types and causes of pediatric stroke is necessary to facilitate early diagnosis, intervention, and prevention in high-risk children. Pediatric stroke also is an area in need of extensive clinical research to help understand the many complex pathophysiologies and outcomes and to determine the optimal treatment strategy for each type of stroke.

References

1. Office of Statistics and Programming, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention. 10 Leading causes of death by age group, United States—2009. http://www.cdc.gov/Injury/wisqars/pdf/10LCD-Age-Grp-US-2009-a.pdf, 2012. [Accessed October 22].

2. Lynch, JK, Hirtz, DG, DeVeber, G, et al. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics. 2002;109(1):116–123.

3. Ozduman, K, Pober, BR, Barnes, P, et al. Fetal stroke. Pediatr Neurol. 2004;30(3):151–162.

4. Tarui, T, Khwaja, OS, Estroff, JA, et al. Fetal MR imaging evidence of prolonged apparent diffusion coefficient decrease in fetal death. AJNR Am J Neuroradiol. 2011;32(7):E126–E128.

5. Deveber, G. Paediatric stroke. Who should be treated? Hamostaseologie. 2009;29(1):88–90.

6. Rodrigues, K, Grant, PE. Diffusion-weighted imaging in neonates. Neuroimaging Clin N Am. 2011;21(1):127–151.

7. Chen, J, Licht, DJ, Smith, SE, et al. Arterial spin labeling perfusion MRI in pediatric arterial ischemic stroke: initial experiences. J Magn Reson Imaging. 2009;29(2):282–290.

8. deVeber, G, Andrew, M, Adams, C, et al. Canadian Pediatric Ischemic Stroke Study Group: Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345(6):417–423.

9. Agrawal, N, Johnston, SC, Wu, YW, et al. Imaging data reveal a higher pediatric stroke incidence than prior US estimates. Stroke. 2009;40(11):3415–3421.

10. Beslow, LA, Jordan, LC. Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations. Childs Nerv Syst. 2010;26(10):1263–1273.

11. Mackay, MT, Wiznitzer, M, Benedict, SL, et al. International Pediatric Stroke Study Group: Arterial ischemic stroke risk factors: the International Pediatric Stroke Study. Ann Neurol. 2011;69(1):130–140.

12. Adams, RJ, McKie, VC, Hsu, L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5–11.

13. Smith, ER, Scott, RM. Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. J Neurosurg Pediatr. 2012;9(4):353–360.

14. Stence, NV, Fenton, LZ, Goldenberg, NA, et al. Craniocervical arterial dissection in children: diagnosis and treatment. Curr Treat Options Neurol. 2011;13(6):636–648.

15. Ming, X, Yacoub, H, Khanna, A, et al. Two young patients with stroke in conjunction with migraineus headache. Open Neurol J. 2010;15(4):111–116.

16. Jackson, BF, Porcher, FK, Zapton, DT, et al. Cerebral sinovenous thrombosis in children: diagnosis and treatment. Pediatr Emerg Care. 2011;27(9):874–880.